The one-stop recurrent miscarriage clinic: an evaluation of its effectiveness and outcome

被引:21
作者
Habayeb, OMH [1 ]
Konje, JC [1 ]
机构
[1] Univ Leicester, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester Royal Infirm, Leicester, Leics, England
关键词
one-stop clinic; recurrent miscarriage;
D O I
10.1093/humrep/deh532
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Couples with recurrent miscarriages make several visits to specialized clinics for investigations before treatment is offered. Consequently, 'the interval' between receipt of referral and advice to try for a pregnancy is often lengthy. The objectives of this study were to examine the effect of a 'one-stop' clinic on 'the interval', throughput and the outcome from this clinic. Methods: The processes for investigation, management and outcomes of 189 couples seen in our Recurrent Miscarriage Clinic (RMC) and their records were reviewed. Results: The one-stop clinic reduced the interval and number of visits by 36% (206.6 to 130.4 days, P<0.001) and by 60% (2.5 to 1, P<0.002) respectively. The prevalence and frequency of aetiological factors were similar in those with two and three or more miscarriages (41% versus 45%, P>0.05). The commonest aetiological factors were thrombophilias (14%) and antiphospholipid syndrome (11%). No cause was identified in 54% of cases. The pregnancy and live birth rates were best in the idiopathic group (75%), those with thrombophilias (64%) and autoimmune antibodies (83%). Older couples had the worse pregnancy rates and outcome. Conclusion: A one-stop clinic significantly shortens 'the interval' between referral and initiation of treatment. Investigations should be initiated in women after two consecutive miscarriages.
引用
收藏
页码:2952 / 2958
页数:7
相关论文
共 24 条
[1]  
Brenner B, 2000, THROMB HAEMOSTASIS, V83, P693
[2]   Action of anticardiolipin and antibodies to β2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death [J].
Chamley, LW ;
Duncalf, AM ;
Mitchell, MD ;
Johnson, PM .
LANCET, 1998, 352 (9133) :1037-1038
[3]   Future pregnancy outcome in unexplained recurrent first trimester miscarriage [J].
Clifford, K ;
Rai, R ;
Regan, L .
HUMAN REPRODUCTION, 1997, 12 (02) :387-389
[4]   INTRAVENOUS IMMUNOGLOBULIN FOR TREATMENT OF RECURRENT PREGNANCY LOSS [J].
COULAM, CB ;
KRYSA, L ;
STERN, JJ ;
BUSTILLO, M .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1995, 34 (06) :333-337
[5]   Mid-trimester loss - appraisal of a screening protocol [J].
Drakeley, AJ ;
Quenby, S ;
Farquharson, RG .
HUMAN REPRODUCTION, 1998, 13 (07) :1975-1980
[6]   Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment [J].
Farquharson, RG ;
Quenby, S ;
Greaves, M .
OBSTETRICS AND GYNECOLOGY, 2002, 100 (03) :408-413
[7]  
Grandone E, 1997, THROMB HAEMOSTASIS, V77, P822
[8]   Obstetric outcome in antiphospholipid syndrome [J].
Granger, KA ;
Farquharson, RG .
LUPUS, 1997, 6 (06) :509-513
[9]   Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone [J].
Kutteh, WH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (05) :1584-1589
[10]   Recurrent miscarriage: aetiology, management and prognosis [J].
Li, TC ;
Makris, M ;
Tomsu, M ;
Tuckerman, E ;
Laird, S .
HUMAN REPRODUCTION UPDATE, 2002, 8 (05) :463-481